Beginner's Mind
Blueprints for Builders and Investors
Hosted by Christian Soschner
From pre-seed to post-IPO, every company—especially in deep tech, biotech, AI, and climate tech—lives or dies by the frameworks it follows.
On Beginner’s Mind, Christian Soschner uncovers the leadership principles behind the world’s most impactful companies—through deep-dive interviews, strategic book reviews, and patterns drawn from history’s greatest business, military, and political minds.
With over 200 interviews, panels, and livestreams, the show ranks in the Top 10% globally—and is recognized as the #1 deep tech podcast.
With 35+ years across M&A, company building, board roles, business schools, ultrarunning, and martial arts, Christian brings a rare lens:
What it really takes to turn breakthrough science into business—how to grow it, lead it, and shape the world around it.
🎙 Expect each episode to deliver:
- Founder & Investor Blueprints: How breakthrough technologies scale from lab to IPO
- Historical & Biographical Frameworks: Timeless playbooks from the world's great builders
- Leadership & Communication Mastery: Tools to inspire, persuade, and lead at scale
Whether you're building the next biotech success, investing in AI, or leading a climate tech company through hypergrowth—this podcast gives you the edge.
Listen in. Apply what matters. Build companies that last.
📬 Join the newsletter & community: https://lsg2g.substack.com/
Beginner's Mind
#12: Vaccine Development
The current pandemic SARS Cov 2 is shining a light on vaccine development. Since December 2019, the novel coronavirus is known amongst scientists. The virus is highly contagious. As a first measure, many governments all over the world have ordered a complete lockdown of the countries.
Some politicians make reverting life back to normal dependent on the existence of medication and/or vaccine. How long does it take to develop a vaccine against this novel coronavirus?
In this episode, the vaccine development expert Erich Tauber, CEO, and founder of Themis Bioscience, explains what it takes to develop a novel vaccine and also gives an outlook on the timeline.
It was a huge pleasure to be accompanied by Elisabeth Pfneisl, Addendum.org, during the recording of this interview.
Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Elisabeth Pfneisl (https://www.linkedin.com/in/elisabeth-pfneisl-81095163/)
Erich Tauber (https://www.linkedin.com/in/erich-tauber-0ba8a111/)
Companies:
Addendum.org (https://www.addendum.org/)
CS Life Science Invest (https://www.cslifescienceinvest.com/)
Themis BioScience (https://themisbio.com/)
Do you enjoy the podcast?
Become a member of the LSG2G Network and join the recording. You will get an individual "member only" invitation and will have a chance to talk with the speakers directly in the Q&A. The questions will be featured in the podcast.
Do you like this idea? Join today: https://www.lifescienceget2gether.com/registration-membersclub/
Join the Podcast Newsletter: Link
